Yu Lin

1.7k total citations
25 papers, 1.4k citations indexed

About

Yu Lin is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Yu Lin has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Molecular Biology. Recurrent topics in Yu Lin's work include Cardiac Ischemia and Reperfusion (11 papers), Cardiac Imaging and Diagnostics (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Yu Lin is often cited by papers focused on Cardiac Ischemia and Reperfusion (11 papers), Cardiac Imaging and Diagnostics (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Yu Lin collaborates with scholars based in United States, Poland and China. Yu Lin's co-authors include Yumei Ye, Yochai Birnbaum, J. R. Perez‐Polo, Barry F. Uretsky, Ming-He Huang, Zhaoyong Hu, Regino Perez‐Polo, Sheldon Y. Freeberg, Shawn Nishi and Kyle T. Keyes and has published in prestigious journals such as Circulation, The Journal of Immunology and Cardiovascular Research.

In The Last Decade

Yu Lin

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Lin United States	20	477	421	320	287	241	25	1.4k
Tao-Cheng Wu Taiwan	25	887 1.9×	638 1.5×	336 1.1×	149 0.5×	270 1.1×	53	2.1k
Costantina Manes Germany	11	428 0.9×	553 1.3×	464 1.4×	104 0.4×	236 1.0×	18	1.5k
Evren Caglayan Germany	24	502 1.1×	507 1.2×	334 1.0×	339 1.2×	120 0.5×	62	1.7k
Sajoscha Sorrentino Germany	11	462 1.0×	365 0.9×	343 1.1×	101 0.4×	130 0.5×	17	1.3k
Włodzimierz J. Musiał Poland	22	420 0.9×	877 2.1×	434 1.4×	129 0.4×	93 0.4×	146	2.0k
Mary Jane Geiger United States	20	452 0.9×	552 1.3×	748 2.3×	218 0.8×	237 1.0×	31	2.5k
Zhen-Yan Fu China	23	502 1.1×	455 1.1×	475 1.5×	115 0.4×	210 0.9×	131	1.7k
Haibing Chen China	25	716 1.5×	249 0.6×	218 0.7×	176 0.6×	168 0.7×	93	1.9k
Chiara Cuccurullo Italy	16	280 0.6×	430 1.0×	255 0.8×	89 0.3×	135 0.6×	30	1.6k
Clarice Kazue Fujihara Brazil	28	563 1.2×	521 1.2×	255 0.8×	134 0.5×	86 0.4×	63	2.2k

Countries citing papers authored by Yu Lin

Since Specialization

Citations

This map shows the geographic impact of Yu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lin more than expected).

Fields of papers citing papers by Yu Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lin. The network helps show where Yu Lin may publish in the future.

Co-authorship network of co-authors of Yu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Lin. A scholar is included among the top collaborators of Yu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Lin. Yu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai, Yu‐Hsien, et al.. (2017). Hazards of antithrombotic therapy on hemodialysis patients with atrial fibrillation and high thromboembolic risk: A Taiwanese population-based cohort study. 10(9). 13982–13991. 2 indexed citations

Duarte, Alexander G., Yu Lin, & Gulshan Sharma. (2016). Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study. The Journal of Heart and Lung Transplantation. 36(2). 220–226. 12 indexed citations

Singh, Siddhartha, Yu Lin, Yong Fang Kuo, Ann B. Nattinger, & James S. Goodwin. (2013). Variation in the Risk of Readmission Among Hospitals: The Relative Contribution of Patient, Hospital and Inpatient Provider Characteristics. Journal of General Internal Medicine. 29(4). 572–578. 66 indexed citations

Sheffield, Kristin M., et al.. (2011). Surveillance of Pancreatic Cancer Patients after Surgical Resection. Annals of Surgical Oncology. 19(5). 1670–1677. 47 indexed citations

Ye, Yumei, et al.. (2010). Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia–reperfusion injury. Cardiovascular Research. 87(3). 535–544. 186 indexed citations

Ye, Yumei, et al.. (2010). Additive Effect of TAK-491, a New Angiotensin Receptor Blocker, and Pioglitazone, in Reducing Myocardial Infarct Size. Cardiovascular Drugs and Therapy. 24(2). 107–120. 12 indexed citations

Ye, Yumei, et al.. (2010). The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. American Journal of Physiology-Heart and Circulatory Physiology. 298(5). H1454–H1465. 130 indexed citations

Ye, Yumei, Yu Lin, J. R. Perez‐Polo, et al.. (2008). Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production. The Journal of Immunology. 181(5). 3515–3523. 50 indexed citations

Ye, Yumei, et al.. (2008). The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin. American Journal of Physiology-Heart and Circulatory Physiology. 295(1). H343–H351. 72 indexed citations

10.

Ye, Yumei, et al.. (2008). Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice. American Journal of Physiology-Heart and Circulatory Physiology. 295(6). H2436–H2446. 45 indexed citations

11.

Ye, Yumei, Yu Lin, J. R. Perez‐Polo, & Yochai Birnbaum. (2008). Oral Glyburide, But Not Glimepiride, Blocks the Infarct-Size Limiting Effects of Pioglitazone. Cardiovascular Drugs and Therapy. 22(6). 429–436. 19 indexed citations

12.

Ye, Yumei, Yu Lin, Regino Perez‐Polo, et al.. (2007). The Cardioprotective Effect of a Statin and Cilostazol Combination: Relationship to Akt and Endothelial Nitric Oxide Synthase Activation. Cardiovascular Drugs and Therapy. 21(5). 321–330. 70 indexed citations

13.

Ye, Yumei, Shawn Nishi, Yu Lin, et al.. (2007). Activation of peroxisome proliferator-activated receptor-γ (PPAR-γ) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2. Prostaglandins & Other Lipid Mediators. 84(1-2). 43–53. 27 indexed citations

14.

Atar, Shaul, Robert J. Siegel, Yumei Ye, et al.. (2007). Ultrasound at 27 kHz Increases Tissue Expression and Activity of Nitric Oxide Synthases in Acute Limb Ischemia in Rabbits. Ultrasound in Medicine & Biology. 33(9). 1483–1488. 16 indexed citations

15.

Huang, Ming-He, Hui-Qun Wang, William R. Roeske, et al.. (2007). Mediating δ-opioid-initiated heart protection via the β₂-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H376–H384. 31 indexed citations

16.

Birnbaum, Yochai, Yu Lin, Yumei Ye, et al.. (2007). Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. American Journal of Physiology-Heart and Circulatory Physiology. 292(6). H2891–H2897. 28 indexed citations

17.

Ye, Yumei, Yu Lin, Regino Perez‐Polo, et al.. (2007). Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H813–H818. 44 indexed citations

18.

Birnbaum, Yochai, Yumei Ye, Yu Lin, et al.. (2006). Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. Prostaglandins & Other Lipid Mediators. 83(1-2). 89–98. 44 indexed citations

19.

Ye, Yumei, Yu Lin, Shaul Atar, et al.. (2006). Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. American Journal of Physiology-Heart and Circulatory Physiology. 291(3). H1158–H1169. 69 indexed citations

20.

Hu, Jiaxin, et al.. (2005). Mechanism of Myocardial Microvessel Formation in Cyanotic Congenital Heart Disease. Circulation Journal. 69(9). 1089–1093. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact